Seeing Beyond Light Obscuration with Micro-Flow Imaging

Subvisible particles are a critical quality attribute for pharmaceutical products as protein aggregates can elicit an immunogenic response that affects the therapeutic's efficacy. Current contamination detection methods, like Light Obscuration (LO), are limited in their ability to detect all particulate matter, creating more risk during QC or when you need to file New Drug Applications (NDAs). Micro-Flow Imaging® (MFI) fills in those gaps because it sees particles LO can’t - making it the perfect complement for your regulatory submissions. The system classifies proteins and non-protein particles and gives you direct, image-based detection of size, count and shape for sub-visible particles between 1-300 microns in solution. Learn more about MFI: www.proteinsim...